178 related articles for article (PubMed ID: 31952902)
1. Prediction of cancer neoepitopes needs new rules.
Brennick CA; George MM; Srivastava PK; Karandikar SH
Semin Immunol; 2020 Feb; 47():101387. PubMed ID: 31952902
[TBL] [Abstract][Full Text] [Related]
2. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
3. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
Front Immunol; 2018; 9():99. PubMed ID: 29441070
[TBL] [Abstract][Full Text] [Related]
4. New epitopes in ovalbumin provide insights for cancer neoepitopes.
Karandikar SH; Sidney J; Sette A; Selby MJ; Korman AJ; Srivastava PK
JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869653
[TBL] [Abstract][Full Text] [Related]
5. An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection.
Brennick CA; George MM; Moussa MM; Hagymasi AT; Seesi SA; Shcheglova TV; Englander RP; Keller GL; Balsbaugh JL; Baker BM; Schietinger A; Mandoiu II; Srivastava PK
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33320837
[TBL] [Abstract][Full Text] [Related]
6. HLA-binding properties of tumor neoepitopes in humans.
Fritsch EF; Rajasagi M; Ott PA; Brusic V; Hacohen N; Wu CJ
Cancer Immunol Res; 2014 Jun; 2(6):522-9. PubMed ID: 24894089
[TBL] [Abstract][Full Text] [Related]
7. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
Front Immunol; 2021; 12():592031. PubMed ID: 34335558
[TBL] [Abstract][Full Text] [Related]
8. Immunization with short peptide particles reveals a functional CD8
He X; Zhou S; Dolan M; Shi Y; Wang J; Quinn B; Jahagirdar D; Huang WC; Tsuji M; Pili R; Ito F; Ortega J; Abrams SI; Ebos JML; Lovell JF
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34862254
[TBL] [Abstract][Full Text] [Related]
9. Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development.
Zaidi N; Soban M; Chen F; Kinkead H; Mathew J; Yarchoan M; Armstrong TD; Haider S; Jaffee EM
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32879142
[TBL] [Abstract][Full Text] [Related]
10. Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy.
Wilson EA; Anderson KS
Expert Rev Proteomics; 2018 Dec; 15(12):1065-1077. PubMed ID: 30408427
[TBL] [Abstract][Full Text] [Related]
11. Characterizing neoantigens for personalized cancer immunotherapy.
Capietto AH; Jhunjhunwala S; Delamarre L
Curr Opin Immunol; 2017 Jun; 46():58-65. PubMed ID: 28478383
[TBL] [Abstract][Full Text] [Related]
12. Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity.
Duan F; Duitama J; Al Seesi S; Ayres CM; Corcelli SA; Pawashe AP; Blanchard T; McMahon D; Sidney J; Sette A; Baker BM; Mandoiu II; Srivastava PK
J Exp Med; 2014 Oct; 211(11):2231-48. PubMed ID: 25245761
[TBL] [Abstract][Full Text] [Related]
13. Neoepitopes-based vaccines: challenges and perspectives.
Alcazer V; Bonaventura P; Tonon L; Wittmann S; Caux C; Depil S
Eur J Cancer; 2019 Feb; 108():55-60. PubMed ID: 30648630
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection.
Ebrahimi-Nik H; Michaux J; Corwin WL; Keller GL; Shcheglova T; Pak H; Coukos G; Baker BM; Mandoiu II; Bassani-Sternberg M; Srivastava PK
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31219806
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.
Türeci Ö; Vormehr M; Diken M; Kreiter S; Huber C; Sahin U
Clin Cancer Res; 2016 Apr; 22(8):1885-96. PubMed ID: 27084742
[TBL] [Abstract][Full Text] [Related]
16. HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.
Hu W; He M; Li L
PLoS One; 2020; 15(2):e0229327. PubMed ID: 32106223
[TBL] [Abstract][Full Text] [Related]
17. Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
Ade CM; Sporn MJ; Das S; Yu Z; Hanada KI; Qi YA; Maity T; Zhang X; Guha U; Andresson T; Yang JC
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37758652
[TBL] [Abstract][Full Text] [Related]
18. Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy.
Lee KL; Benz SC; Hicks KC; Nguyen A; Gameiro SR; Palena C; Sanborn JZ; Su Z; Ordentlich P; Rohlin L; Lee JH; Rabizadeh S; Soon-Shiong P; Niazi K; Schlom J; Hamilton DH
Cancer Immunol Res; 2019 Aug; 7(8):1359-1370. PubMed ID: 31292145
[TBL] [Abstract][Full Text] [Related]
19. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
